2802 Phase II study of first-line paclitaxel (PTX) with panitumumab (P) in patients with metastatic or recurrent head and neck cancer: TTCC-2009-03 study

Autor: Del Barco Morillo, E., Mesia, R., Adansa Klain, J.C., Fernández, S. Vazquez, Galan, J. Martínez, Borgoñnon, M. Pastor, Rivas, C. González, Caballero Daroqui, J., Berrocal, A., Trufero, J. Martínez, Cruz Hernández, J.J., Vera, R.
Zdroj: In European Journal of Cancer September 2015 51 Supplement 3:S558-S558
Databáze: ScienceDirect
Externí odkaz: